The Food and Drug Administration algorithm. Special workshop--regulatory

Area of Science:

• Pharmacovigilance
• Drug Safety
• Regulatory Science

Background:

• The Food and Drug Administration (FDA) receives and evaluates over 40,000 adverse drug effect case reports each year.
• Ensuring drug safety requires objective evaluation of reported adverse events to determine causality.

Purpose of the Study:

• To introduce the algorithm utilized by the FDA Division of Drug Experience for assessing causal relationships between drugs and adverse reactions.
• To provide essential information for applying the FDA's causal assessment algorithm.

Main Methods:

• Objective review and evaluation of individual adverse drug effect case reports.
• Causal association assessment based on four core principles: temporal eligibility, dechallenge and outcome, rechallenge and outcome, and confounding factors.

Main Results:

• The FDA employs a systematic approach to evaluate the likelihood of a causal link between a drug and a reported adverse event.
• The described algorithm provides a structured framework for consistent and objective causality assessments.

Conclusions:

• The FDA's established algorithm offers a reliable method for determining causal relationships in adverse drug event reports.
• Understanding and applying this algorithm is crucial for effective drug safety monitoring and regulatory decision-making.